Please join us by contacting your elected officials to urge them to halt plans to end coverage of GLP-1 weight-loss medications for TFL beneficiaries
trp-2(gk298) double mutant exhibits wild-type GLP-1::V5 expression and PZ germ cell number (Fig
Automated Alerts: Patients can sign-up to receive automated email alerts, delivered when a GLP-1 drug is reported in supply in their area or when the status of a GLP-1 drug changes on the FDA's Drug Shortage List
Published Phase 2 data shows: Dose Group Discontinuation Due to AE Placebo 0% 1 mg 2.9% 4 mg (escalated) 5.7% 8 mg (escalated) 5.0% 12 mg (escalated) 8.3% For context, discontinuation rates in semaglutide 2.4 mg trials (STEP program) were approximately 7%, and tirzepatide 15 mg trials (SURMOUNT) reported approximately 6-7%
If you take oral semaglutide (Rybelsus), it must also be taken on an empty stomach with no more than 4 ounces of plain water, at least 30 minutes before other oral medications, food, or drink
Your healthcare provider can assess your symptoms, rule out any potential risks, and make adjustments to your treatment plan to help you feel better